NEWARK, Del, April 27, 2023 (GLOBE NEWSWIRE) -- The global superficial punctate keratitis treatment market is slated to reach a valuation of US$ 5.3 Billion in 2023. According to Future Market ...

The global superficial punctate keratitis treatment market is slated to reach a valuation of US$ 5.3 billion in 2023. According to Future Market Insights, the market is expected to grow at a 6.33% ...

In addition to 'Superficial punctate keratopathy', there may be other similar symptoms or signs that better match your side effect. These have also been listed below for your convenience.

Compr Ophthalmol Update. 2005;6(2):85-101. In a 10-week study of three times daily oral acyclovir against placebo, pediatric patients with HSV stromal keratitis who were treated concomitantly with ...

Amgen (AMGN) announced on Monday that a late-stage study evaluating its Bemarituzumab in combination with chemotherapy met ...

To evaluate blinking patterns in patients with diabetes mellitus and whether blinking contributes to the formation of superficial punctate keratopathy in diabetic patients. We examined 163 ...

NEW ALBANY, Ind. — A new approach to treating Thygeson’s superficial punctate keratitis, a rare chronic bilateral corneal disorder, could be application of a topical cyclosporine solution.

Diagnosis of Thygeson's superficial punctate keratitis is made if multiple, punctate, whitish lesions occur in the corneal epithelium. 1,2,3,4,5,6 Similar, but not identical, corneal epithelial ...

Bemarituzumab targets FGFR2b, which has been found to be overexpressed in approximately 30% of patients with non-HER2 positive gastric cancer.

Did you know that certain medications can cause symptom of 'Punctate keratitis'. Find these drugs listed on the page and be warned of similar symptoms as possible side-effects.